×

Exclusive Insights on Technology Transfer Challenges: A Conversation with Roberto Formisano of AGC Biologics

Current developments in technology transfer to a Contract Development and Manufacturing Organization (CDMO)

Exclusive Insights on Technology Transfer Challenges: A Conversation with Roberto Formisano of AGC Biologics

In an exclusive interview with EPR editor Caroline Peachey, Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, shared his thoughts on the challenges associated with technology transfer. He offered insights into the nuances of technology transfer, both from development to GMP manufacturing and from a customer to a contract development and manufacturing organization (CDMO).

During the interview, Roberto highlighted one of the key challenges in the industry: balancing the number of batches that need to be manufactured while adhering to critical timelines. This challenge is integral to the process of technology transfer and poses significant difficulties for many organizations.

In addition to discussing timelines, Roberto also shared his predictions on technology and manufacturing trends that are expected to shape the cell and gene therapy industry by 2024. His insights provided valuable perspectives on the future direction of the industry and shed light on some of its most pressing challenges.

Roberto’s conversation with Caroline Peachey took place at Terrapin’s Advanced Therapies conference in London on 19 March. The interview offers valuable insights into the complexities of technology transfer and highlights some of the key issues facing organizations in this rapidly evolving field.

You May Have Missed